Treatment of Medication-Related Osteonecrosis of the Jaw Without and With the Use of Advanced Platelet-Rich Fibrin: A Retrospective Clinical Study
Background: Medication-related osteonecrosis of the jaw (MRONJ) is drug-induced bone destruction that is exposed for a minimum of 6 to 8 weeks in patients who have not received head and neck radiotherapy and who have not been diagnosed with facial bone metastases. MRONJ treatment outcomes are unpred...
Saved in:
| Main Authors: | Paulina Adamska, Marcin Stasiak, Natalia Kobusińska, Michał Bartmański, Adam Zedler, Michał Studniarek |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Journal of Functional Biomaterials |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-4983/16/5/180 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Platelet Rich Fibrin (PRF) in the Management of Osteonecrosis of the Jaw: A Narrative Review
by: A F M Shakilur Rahman
Published: (2025-04-01) -
Effectiveness of Leukocyte- and Platelet-rich Fibrin in the Management of Medication-related Osteonecrosis of the Jaws – A Systematic Review
by: Rahul Mohandas, et al.
Published: (2024-01-01) -
Application of Advanced Platelet-Rich Fibrin in Oral and Maxillo-Facial Surgery: A Systematic Review
by: Marek Chmielewski, et al.
Published: (2024-12-01) -
Advanced Platelet-Rich Fibrin Plus (A-PRF+) as an Additive to Hard Tissue Managing Protocols in Oral Surgery: A Systematic Review
by: Marek Chmielewski, et al.
Published: (2025-04-01) -
Use of Platelet-Rich Fibrin for Jaw Osteonecrosis: A Case Report
by: Petya Kanazirska, et al.
Published: (2020-12-01)